Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Association between osteoarthritis and increased risk of dementia: A systemic review and meta-analysis.

Weber A, Mak SH, Berenbaum F, Sellam J, Zheng YP, Han Y, Wen C.

Medicine (Baltimore). 2019 Mar;98(10):e14355. doi: 10.1097/MD.0000000000014355.

2.

A Phase 2 Trial of Lutikizumab, an Anti-Interleukin 1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC.

Arthritis Rheumatol. 2019 Jan 17. doi: 10.1002/art.40840. [Epub ahead of print]

PMID:
30653843
3.

Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development.

Wittoek R, Kroon FPB, Kundakci B, Abhishek A, Haugen IK, Berenbaum F, Conaghan PG, Ishimori ML, Smeets W, van der Heijde D, Kloppenburg M.

J Rheumatol. 2019 Jan 15. pii: jrheum.181003. doi: 10.3899/jrheum.181003. [Epub ahead of print]

PMID:
30647176
4.

Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis.

Trellu S, Courties A, Jaisson S, Gorisse L, Gillery P, Kerdine-Römer S, Vaamonde-Garcia C, Houard X, Ekhirch FP, Sautet A, Friguet B, Jacques C, Berenbaum F, Sellam J.

Arthritis Res Ther. 2019 Jan 11;21(1):18. doi: 10.1186/s13075-018-1801-y.

5.

The Phenotypic Approach to Osteoarthritis: A Look at Metabolic Syndrome-Associated Osteoarthritis.

Courties A, Berenbaum F, Sellam J.

Joint Bone Spine. 2018 Dec 22. pii: S1297-319X(18)30444-5. doi: 10.1016/j.jbspin.2018.12.005. [Epub ahead of print]

PMID:
30584921
6.

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.

Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, Liu W, Levy G, Fleischmann RM, Berenbaum F, van der Heijde D, Bansal P, Wittoek R, Feng S, Fang Y, Saltarelli M, Medema JK, Levesque MC.

Ann Rheum Dis. 2019 Mar;78(3):413-420. doi: 10.1136/annrheumdis-2018-213336. Epub 2018 Dec 14.

7.

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis.

Ruiz M, Maumus M, Fonteneau G, Pers YM, Ferreira R, Dagneaux L, Delfour C, Houard X, Berenbaum F, Rannou F, Jorgensen C, Noël D.

Osteoarthritis Cartilage. 2019 Mar;27(3):493-503. doi: 10.1016/j.joca.2018.11.005. Epub 2018 Nov 28.

8.

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, Klatzmann D.

Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24.

PMID:
30472651
9.

Targeting nerve growth factor to relieve pain from osteoarthritis: What can we expect?

Berenbaum F.

Joint Bone Spine. 2019 Mar;86(2):127-128. doi: 10.1016/j.jbspin.2018.09.009. Epub 2018 Sep 26. No abstract available.

PMID:
30266445
10.

Modern-day environmental factors in the pathogenesis of osteoarthritis.

Berenbaum F, Wallace IJ, Lieberman DE, Felson DT.

Nat Rev Rheumatol. 2018 Nov;14(11):674-681. doi: 10.1038/s41584-018-0073-x. Review.

11.

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol.

Lorenzon R, Mariotti-Ferrandiz E, Aheng C, Ribet C, Toumi F, Pitoiset F, Chaara W, Derian N, Johanet C, Drakos I, Harris S, Amselem S, Berenbaum F, Benveniste O, Bodaghi B, Cacoub P, Grateau G, Amouyal C, Hartemann A, Saadoun D, Sellam J, Seksik P, Sokol H, Salem JE, Vicaut E, Six A, Rosenzwajg M, Bernard C, Klatzmann D.

BMJ Open. 2018 Aug 30;8(8):e021037. doi: 10.1136/bmjopen-2017-021037.

12.

Deep phenotyping of osteoarthritis: a step forward.

Berenbaum F.

Ann Rheum Dis. 2019 Jan;78(1):3-5. doi: 10.1136/annrheumdis-2018-213864. Epub 2018 Aug 28. No abstract available.

PMID:
30154088
13.

Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2659. doi: 10.1007/s10067-018-4241-9.

14.

Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.

Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A.

Clin Rheumatol. 2018 Oct;37(10):2649-2657. doi: 10.1007/s10067-018-4172-5. Epub 2018 Jun 12. Erratum in: Clin Rheumatol. 2018 Aug 24;:.

15.

Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.

Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A, Chanson P, Taoufik Y, Wendling D, Lories R, Berenbaum F, van den Berg R, Claudepierre P, Feydy A, Dougados M, Roux C, Miceli-Richard C.

Sci Rep. 2018 May 16;8(1):7731. doi: 10.1038/s41598-018-25722-z.

16.

Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss.

Parsons CM, Judge A, Leyland K, Bruyère O, Petit Dop F, Chapurlat R, Reginster JY, Edwards MH, Dennison EM, Cooper C, Inskip H; SEKOIA Study Group.

Arthritis Care Res (Hoboken). 2019 Feb;71(2):300-307. doi: 10.1002/acr.23596.

PMID:
29741284
17.

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.

Conaghan PG, Hunter DJ, Cohen SB, Kraus VB, Berenbaum F, Lieberman JR, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ, Lufkin J, Johnson JR, Bodick N; FX006-2014-008 Participating Investigators.

J Bone Joint Surg Am. 2018 Apr 18;100(8):666-677. doi: 10.2106/JBJS.17.00154.

18.

Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: Data from the early arthritis ESPOIR cohort.

Daïen CI, Sellam J, Rincheval N, Fautrel B, Saraux A, Morel J, Berenbaum F, Daurès JP, Combe B.

Joint Bone Spine. 2018 Dec;85(6):773-775. doi: 10.1016/j.jbspin.2018.02.004. Epub 2018 Feb 23. No abstract available.

PMID:
29481873
19.

Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis.

Baudart P, Louati K, Marcelli C, Berenbaum F, Sellam J.

RMD Open. 2017 Aug 29;3(2):e000442. doi: 10.1136/rmdopen-2017-000442. eCollection 2017.

20.

Challenges and Advances in Targeting Remission in Axial Spondyloarthritis.

Baraliakos X, Berenbaum F, Favalli EG, Olivieri I, Ostendorf B, Poddubnyy D, DE Vlam K.

J Rheumatol. 2018 Feb;45(2):153-157. doi: 10.3899/jrheum.170222. No abstract available.

Supplemental Content

Loading ...
Support Center